IMR Press / FBL / Volume 13 / Issue 2 / DOI: 10.2741/2703

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
TWEAKing renal injury
Show Less
1 Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, 2040 Madrid, Spain
2 Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain
Front. Biosci. (Landmark Ed) 2008, 13(2), 580–589; https://doi.org/10.2741/2703
Published: 1 January 2008
Abstract

TWEAK is a recently identified cytokine of the TNF superfamiliy. Through activation of the Fn14 receptor, TWEAK regulates cell proliferation, cell death and inflammation. Recent studies show increased TWEAK and Fn14 expression in tubular cells during acute kidney injury as well as elevated urinary TWEAK levels in patients with active lupus nephritis. Furthermore, glomerular mesangial cells and renal tubular epithelial cells express the Fn14 receptor under the regulation of proinflammatory cytokines. TWEAK weakly increases cell death and promotes secretion of inflammatory mediators in non-stimulated mesangial cells. In addition, in a proinflammatory milieu, TWEAK induces apoptosis of mesangial and tubular cells. The available data suggest that TWEAK is a new player in kidney injury both at the glomerular and tubulointerstitial levels and might be a target for therapeutic intervention.

Share
Back to top